A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Issue 3 (3rd March 2020)

• Record Type: Journal Article
• Authors: Sawan, Mouna; Reeve, Emily; Turner, Justin; Todd, Adam; Steinman, Michael A.; Petrovic, Mirko; Gnjidic, Danijela
• Is Part Of: Expert review of clinical pharmacology. Volume 13:Issue 3(2020)
• Page Start: 233
• Page End: 245
• Publication Date: 2020-03-03
• Subjects: Deprescribing -- deprescribing in practice -- medication withdrawal -- older adults -- policies -- polypharmacy; Clinical pharmacology -- Periodicals; 615.105
• DOI: 10.1080/17512433.2020.1730812
• Languages: English
• ISSNs: 1751-2433

Abstract

ABSTRACT: Introduction : There is increasing recognition of the need for deprescribing of inappropriate medications in older adults. However, efforts to encourage implementation of deprescribing in clinical practice have resulted in mixed results across settings and countries. Area covered : Searches were conducted in PubMed, Embase, and Google Scholar in June 2019. Reference lists, citation checking, and personal reference libraries were also utilized. Studies capturing the main challenges of, and opportunities for, implementing deprescribing into clinical practice across selected health-care settings internationally, and international deprescribing-orientated policies were included and summarized in this narrative review. Expert opinion : Deprescribing intervention studies are inherently heterogeneous because of the complexity of interventions employed and often do not reflect the real-world. Further research investigating enhanced implementation of deprescribing into clinical practice and across health-care settings is required. Process evaluations in deprescribing intervention studies are needed to determine the contextual factors that are important to the translation of the interventions in the real-world. Deprescribing interventions may need to be individually tailored to target the unique barriers and opportunities to deprescribing in different clinical settings. Introduction of national policies to encourage deprescribing may be beneficial, but need to be evaluated to determine if there are any unintended consequences.